Skip to main navigation

Back to SpringWorksTx.com
Investors & Media
Contact Us
Linkedin
Twitter

Overview
News & Events
- Press Releases
- Events & Presentations
Corporate Governance
Financial Information
- SEC Filings
- Annual Reports
Stock Information
- Stock Quote & Chart
- Analyst Coverage
Investor Resources
Investors + Media
Medical Professionals
Contact Us
Linkedin
Twitter

Press Releases

Items Per Page

Year

27 Jul 2021

SpringWorks Therapeutics Appoints Dr. James Cassidy as Chief Medical Officer

PDF Version

20 Jul 2021

SpringWorks Therapeutics Announces Issuance of New U.S. Composition of Matter Patent to Polymorphic Form of Mirdametinib, Extending Patent Protection Into 2041

PDF Version

28 Jun 2021

Precision BioSciences and SpringWorks Therapeutics Dose First Patient in Expanded Phase 1/2a Clinical Trial Evaluating PBCAR269A with Nirogacestat in Patients with Relapsed/Refractory Multiple Myeloma

PDF Version

16 Jun 2021

SpringWorks Therapeutics Announces Initiation of Phase 1/2 Clinical Trial of Mirdametinib in Children and Young Adults with Low-Grade Glioma

PDF Version

15 Jun 2021

SpringWorks Therapeutics Announces Presentation of Updated Interim Data from the Phase 2b ReNeu Trial at the 2021 Children’s Tumor Foundation NF Conference

PDF Version

07 Jun 2021

SpringWorks Therapeutics Announces Clinical Collaboration with Seagen to Evaluate Nirogacestat in Combination with SEA-BCMA in Patients with Relapsed or Refractory Multiple Myeloma

PDF Version

01 Jun 2021

SpringWorks Therapeutics to Present at the Goldman Sachs 42nd Annual Global Healthcare Conference

PDF Version

14 May 2021

SpringWorks Therapeutics to Present at the Cowen 2nd Annual Oncology Innovation Summit

PDF Version

10 May 2021

SpringWorks Therapeutics Appoints Dr. Mike Burgess as Head of Research and Development

PDF Version

06 May 2021

SpringWorks Therapeutics Reports First Quarter 2021 Financial Results and Recent Business Highlights

PDF Version

Pagination

First page
Previous page
…
Page 2
Page 3
Page 4
Page 5
Current page 6
Page 7
Page 8
Page 9
Page 10
…
Next page
Last page

Displaying 51 - 60 of 121

Springworks - Toolkits

Print Page
Email Alerts
RSS Feeds
Investor Contacts

Request E-mail Alerts

Social Links

Footer 1

Who We Are
Focus Areas

Footer 2

Pipeline
Careers
- View Opportunities
- Desmoid Tumor Commercial Team

Footer 3

Patients
Contact

Footer 4

Investors & Media

© 2023 SpringWorks Therapeutics. All rights reserved.

Copyright Links

Privacy Policy
Terms of Use
Cookie Policy